Your browser doesn't support javascript.
loading
Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer.
Mahon, K L; Qu, W; Devaney, J; Paul, C; Castillo, L; Wykes, R J; Chatfield, M D; Boyer, M J; Stockler, M R; Marx, G; Gurney, H; Mallesara, G; Molloy, P L; Horvath, L G; Clark, S J.
Affiliation
  • Mahon KL; 1] Chris O'Brien Lifehouse, Missenden Rd, Camperdown, New South Wales, 2050, Australia [2] Cancer Research Division, Garvan Institute of Medical Research/The Kinghorn Cancer Centre, Darlinghurst, New South Wales, 2010, Australia [3] Sydney Medical School, University of Sydney, Camperdown, New South
  • Qu W; Cancer Research Division, Garvan Institute of Medical Research/The Kinghorn Cancer Centre, Darlinghurst, New South Wales, 2010, Australia.
  • Devaney J; Cancer Research Division, Garvan Institute of Medical Research/The Kinghorn Cancer Centre, Darlinghurst, New South Wales, 2010, Australia.
  • Paul C; Cancer Research Division, Garvan Institute of Medical Research/The Kinghorn Cancer Centre, Darlinghurst, New South Wales, 2010, Australia.
  • Castillo L; Cancer Research Division, Garvan Institute of Medical Research/The Kinghorn Cancer Centre, Darlinghurst, New South Wales, 2010, Australia.
  • Wykes RJ; Royal Prince Alfred Hospital, Missenden Rd, Camperdown, New South Wales, 2050, Australia.
  • Chatfield MD; Menzies School of Health Research, Darwin, Northern Territory, Australia.
  • Boyer MJ; 1] Chris O'Brien Lifehouse, Missenden Rd, Camperdown, New South Wales, 2050, Australia [2] Sydney Medical School, University of Sydney, Camperdown, New South Wales, 2050, Australia [3] Royal Prince Alfred Hospital, Missenden Rd, Camperdown, New South Wales, 2050, Australia.
  • Stockler MR; 1] Chris O'Brien Lifehouse, Missenden Rd, Camperdown, New South Wales, 2050, Australia [2] Sydney Medical School, University of Sydney, Camperdown, New South Wales, 2050, Australia [3] NHMRC Clinical Trials Centre, University of Sydney, New South Wales, 2050, Australia.
  • Marx G; 1] Sydney Medical School, University of Sydney, Camperdown, New South Wales, 2050, Australia [2] Northern Haematology and Oncology Group, SAN Clinic, Wahroonga, New South Wales, 2076, Australia.
  • Gurney H; 1] Sydney Medical School, University of Sydney, Camperdown, New South Wales, 2050, Australia [2] Westmead Hospital, Sydney, New South Wales, Australia.
  • Mallesara G; Calvary Mater Newcastle, New South Wales, Australia.
  • Molloy PL; CSIRO Animal, Food and Health Sciences, North Ryde, New South Wales, 2113, Australia.
  • Horvath LG; 1] Chris O'Brien Lifehouse, Missenden Rd, Camperdown, New South Wales, 2050, Australia [2] Cancer Research Division, Garvan Institute of Medical Research/The Kinghorn Cancer Centre, Darlinghurst, New South Wales, 2010, Australia [3] Sydney Medical School, University of Sydney, Camperdown, New South
  • Clark SJ; 1] Cancer Research Division, Garvan Institute of Medical Research/The Kinghorn Cancer Centre, Darlinghurst, New South Wales, 2010, Australia [2] St Vincent's Clinical School, University of NSW, Sydney, 2010, New South Wales, Australia.
Br J Cancer ; 111(9): 1802-9, 2014 Oct 28.
Article in En | MEDLINE | ID: mdl-25144624
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Neoplasm / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / DNA Methylation / Glutathione S-Transferase pi / Epigenomics / Prostatic Neoplasms, Castration-Resistant Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2014 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Neoplasm / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / DNA Methylation / Glutathione S-Transferase pi / Epigenomics / Prostatic Neoplasms, Castration-Resistant Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2014 Document type: Article Country of publication: United kingdom